Sales, founded by Denniz Özden at just 20 years old, is reshaping the B2B lead generation landscape with a results-only model ...

Q2 2025 Earnings Call Transcript August 7, 2025 AbCellera Biologics Inc. beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.17. Operator: Good afternoon, and welcome to ...

Key Points Surrozen reported GAAP EPS of $2.55 for Q2 2025, exceeding expectations by $3.66 per share (GAAP) due to significant one-time and non-cash gains. Surrozen recorded $1.0 million in research ...

Gilead Sciences generates stellar profit margins with its HIV and hepatitis C virus, or HCV, portfolio, which requires only a small salesforce and inexpensive manufacturing. We think its portfolio and ...

Pipeline Regulatory Progress -- Two risk-adjusted product launches (AMP-002 and AMP-015) are included in the flat full-year ...

Dynavax delivers record Q2 results with $92M in HEPLISAV-B revenue, updates 2025 guidance, and advances pipeline milestones.

Key Points Dynavax Technologies (NASDAQ:DVAX) exceeded analyst expectations in Q2 2025, reporting GAAP revenue of $95.4 million and GAAP diluted EPS of $0.14. HEPLISAV-B, Dynavax's two-dose adult ...

President Donald Trump's administration and its allies have pushed aggressively for drilling, mining and logging in Alaska.

Fish camps still dot the banks of the broad Kuskokwim River in southwestern Alaska. Wooden huts and tarped shelters stand ...

Pipedrive’s new tool helps small business sales teams prioritize leads, automate prospecting, and focus on the most promising ...

El Pollo Loco is working through a choppy sales environment, with guests feeling limited on what they can spend. Even with ...

The majority of Teva's business lies in generic and off-patent branded drugs which faces price and volume pressures that will be exacerbated as regulatory actions and other players in the drug supply ...